Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATN-224 plus exemestane versus exemestane alone in post-menopausal women with recurrent or advanced hormone receptor-positive breast cancer
2007-005752-16Phase 2Terminated
- Sponsor
- Cancer Research UK
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetrathiomolybdate, exemestane in breast cancer, sponsored by Cancer Research UK. Started Jan 2008; status: terminated.
02
Drugs
tetrathiomolybdateexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-005752-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005752-16.